164 related articles for article (PubMed ID: 9718068)
1. Synoviocytes from osteoarthritis and rheumatoid arthritis produce plasminogen activators and plasminogen activator inhibitor-1 and display u-PA receptors on their surface.
Cerinic MM; Generini S; Partsch G; Pignone A; Dini G; Konttinen YT; Del Rosso M
Life Sci; 1998; 63(6):441-53. PubMed ID: 9718068
[TBL] [Abstract][Full Text] [Related]
2. Difference in expression of the plasminogen activation system in synovial tissue of patients with rheumatoid arthritis and osteoarthritis.
Ronday HK; Smits HH; Van Muijen GN; Pruszczynski MS; Dolhain RJ; Van Langelaan EJ; Breedveld FC; Verheijen JH
Br J Rheumatol; 1996 May; 35(5):416-23. PubMed ID: 8646430
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis.
Nonaka T; Kikuchi H; Ikeda T; Okamoto Y; Hamanishi C; Tanaka S
J Rheumatol; 2000 Apr; 27(4):997-1004. PubMed ID: 10782829
[TBL] [Abstract][Full Text] [Related]
4. Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis.
Guiducci S; Del Rosso A; Cinelli M; Perfetto F; Livi R; Rossi A; Gabrielli A; Giacomelli R; Iori N; Fibbi G; Del Rosso M; Cerinic MM
Arthritis Res Ther; 2005; 7(6):R1244-53. PubMed ID: 16277677
[TBL] [Abstract][Full Text] [Related]
5. Control of the chondrocyte fibrinolytic balance by the drug piroxicam: relevance to the osteoarthritic process.
Fibbi G; Serni U; Matucci A; Mannoni A; Pucci M; Anichini E; Del Rosso M
J Rheumatol; 1994 Dec; 21(12):2322-8. PubMed ID: 7699636
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activators and plasminogen activator inhibitors in synovial fluid. Difference between inflammatory joint disorders and osteoarthritis.
Saxne T; Lecander I; Geborek P
J Rheumatol; 1993 Jan; 20(1):91-6. PubMed ID: 8441174
[TBL] [Abstract][Full Text] [Related]
7. Effects of tiaprofenic acid on plasminogen activators and inhibitors in human OA and RA synovium.
Pelletier JP; McCollum R; Cloutier JM; Martel-Pelletier J
Br J Rheumatol; 1992; 31 Suppl 1():19-26. PubMed ID: 1555050
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints.
Busso N; Péclat V; So A; Sappino AP
Ann Rheum Dis; 1997 Sep; 56(9):550-7. PubMed ID: 9370880
[TBL] [Abstract][Full Text] [Related]
9. Bone matrix degradation by the plasminogen activation system. Possible mechanism of bone destruction in arthritis.
Ronday HK; Smits HH; Quax PH; van der Pluijm G; Löwik CW; Breedveld FC; Verheijen JH
Br J Rheumatol; 1997 Jan; 36(1):9-15. PubMed ID: 9117184
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of the urokinase receptor (CD87) in arthritic and normal synovial tissues.
Szekanecz Z; Haines GK; Koch AE
J Clin Pathol; 1997 Apr; 50(4):314-9. PubMed ID: 9215148
[TBL] [Abstract][Full Text] [Related]
11. Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis.
Weinberg JB; Pippen AM; Greenberg CS
Arthritis Rheum; 1991 Aug; 34(8):996-1005. PubMed ID: 1677574
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activators and their inhibitors in synovial fluids from normal, osteoarthritis, and rheumatoid arthritis knees.
Belcher C; Fawthrop F; Bunning R; Doherty M
Ann Rheum Dis; 1996 Apr; 55(4):230-6. PubMed ID: 8733439
[TBL] [Abstract][Full Text] [Related]
13. Analysis of intraarticular fibrinolytic pathways in patients with inflammatory and noninflammatory joint diseases.
Kummer JA; Abbink JJ; de Boer JP; Roem D; Nieuwenhuys EJ; Kamp AM; Swaak TJ; Hack CE
Arthritis Rheum; 1992 Aug; 35(8):884-93. PubMed ID: 1379429
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activators in synovial fluid and plasma from patients with arthritis.
Brommer EJ; Dooijewaard G; Dijkmans BA; Breedveld FC
Ann Rheum Dis; 1992 Aug; 51(8):965-8. PubMed ID: 1417121
[TBL] [Abstract][Full Text] [Related]
15. Fibrinolytic activity in the synovial membrane of osteoarthritis.
Matucci-Cerinic M; Lombardi A; Lotti T; Pignone A; Senesi C; Buzzi R; Aglietti P; Partsch G; Cagnoni M
Br J Rheumatol; 1990 Aug; 29(4):249-53. PubMed ID: 2116205
[TBL] [Abstract][Full Text] [Related]
16. Rheumatoid synovial fibroblasts constitutively express the fibrinolytic pattern of invasive tumor-like cells.
Guiducci S; Del Rosso A; Cinelli M; Margheri F; D'Alessio S; Fibbi G; Matucci Cerinic M; Del Rosso M
Clin Exp Rheumatol; 2005; 23(3):364-72. PubMed ID: 15971425
[TBL] [Abstract][Full Text] [Related]
17. Elevations in synovial fluid plasminogen activator in patients with rheumatoid arthritis.
Mochan E; Uhl J
J Rheumatol; 1984 Apr; 11(2):123-8. PubMed ID: 6427461
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator in synovial fluid from patients with rheumatoid arthritis.
Kikuchi H; Tanaka S; Matsuo O
J Rheumatol; 1987 Jun; 14(3):439-45. PubMed ID: 3625626
[TBL] [Abstract][Full Text] [Related]
19. Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytes.
Del Rosso A; Cinelli M; Guiducci S; Pignone A; Fibbi G; Margheri F; Gabrielli A; Giacomelli R; Coppini A; Del Rosso M; Matucci Cerinic M
Rheumatology (Oxford); 2005 Oct; 44(10):1255-62. PubMed ID: 15998634
[TBL] [Abstract][Full Text] [Related]
20. Urokinase-mediated fibrinolysis in the synovial fluid of rheumatoid arthritis patients may be affected by the inactivation of single chain urokinase type plasminogen activator by thrombin.
Braat EA; Jie AF; Ronday HK; Beekman B; Rijken DC
Ann Rheum Dis; 2000 Apr; 59(4):315-8. PubMed ID: 10733483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]